A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis

7.6K views

DOI:

10.3791/56499

January 30th, 2018

In This Article

Summary

Uranium is known to affect bone metabolism. Here, we present a protocol aimed at investigating the effect of natural uranium exposure on the viability, the differentiation, and the function of osteoclasts, the cells in charge of bone resorption.

Abstract

Uranium has been shown to interfere with bone physiology and it is well established that this metal accumulates in bone. However, little is known about the effect of natural uranium on the behavior of bone cells. In particular, the impact of uranium on osteoclasts, the cells responsible for the resorption of the bone matrix, is not documented. To investigate this issue, we have established a new protocol using uranyl acetate as a source of natural uranium and the murine RAW 264.7 cell line as a model of osteoclast precursors. Herein, we detailed all the assays required to test uranium cytotoxicity on osteoclast precursors and to evaluate its impact on the osteoclastogenesis and on the resorbing function of mature osteoclasts. The conditions we have developed, in particular for the preparation of uranyl-containing culture media and for the seeding of RAW 264.7 cells allow to obtain reliable and highly reproductive results. Moreover, we have optimized the use of software tools to facilitate the analysis of various parameters such as the size of osteoclasts or the percentage of resorbed matrix.

Introduction

Uranium is a naturally occurring radioactive element present in soils, air and water; as such, animals and humans are exposed to natural uranium in their diets. In addition to natural sources, uranium originates from anthropogenic activities, which increases its abundance in the environment. Uranium poses both chemical and radiological hazards. However, because natural uranium (which is an isotopic mixture containing 99.27% 238U, 0.72% 235U, and 0.006% 234U) has a low specific activity (25.103 Bq.g-1), its impacts on health are attributed to its chemical toxicity.

Whatever its entry rou....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation of Uranyl Acetate Solution

  1. To prepare 2 mL of a 100 mM uranyl acetate solution, add 85 mg of uranyl acetate (UO2(OCOCH3)2, 2H2O; M = 424 g.mol-1) in solid state to a 5 mL plastic tube.
  2. Add 2 mL of distilled water to the plastic tube and fit it with a plastic stopper.
  3. Shake the tube vigorously until the total dissolution of the solid. Put the solution into the fridge for 24 h.
    CAUTION: The manipulation of uranyl [U(VI)] presents some chemical and radiological hazards. All the samples should be prepared and characterized with ad hoc equipment in specific laborato....

Access restricted. Please log in or start a trial to view this content.

Results

Tartrate-resistant acid phosphatase staining was used to visualize osteoclasts as large purple cells having 3 or more nuclei. Representative images of osteoclasts obtained from RAW 264.7 cells cultured in the presence of RANKL and uranyl ions are shown in Figure 1. Changes in number and size of osteoclasts in response to uranium are easily visible in composite images of whole wells and in enlarged pictures.

Access restricted. Please log in or start a trial to view this content.

Discussion

As far as we know, this is the first time that a detailed procedure aiming to study the effect of natural uranium on bone resorbing cells is described. This approach will be useful to achieve a better understanding of uranium impact on bone physiology and may provide an interesting new tool for the screening of uranium chelators. Furthermore, we believe that the protocol described here could be applied to study the impact of other heavy metals on osteoclatogenesis.

It is known that uranyl is c.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose

Acknowledgements

The authors would like to thank Chantal Cros for helpful technical assistance.
This research was funded by grants from the "Commissariat à l'Energie Atomique et aux Energies Alternatives" (URANOs - Programme Transversal de Toxicologie du CEA and CPRR CEA-AREVA), and from ANR (Toxicity of URanium: Multi-level approach of biomineralization process in BOne, ANR-16-CE34-0003). This work was also supported by the University of Nice Sophia-Antipolis and the CNRS.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
DMEMLonzaBE12-604F
α-MEMLonzaBE12-169F
EMEM without phenol redLonza12-668E
Water for cell cultureLonzaBE17-724F
PBSSigma-AldrichD8537
Penicillin-Streptomycin solutionSigma-AldrichP4333
 L-Glutamine solutionSigma-AldrichG7513
Trypan Blue Solution 0.4%Sigma-AldrichT8154
HyClone fetal bovine serumGE Life SciencesSH30071.03
7.5% sodium bicarbonate aqueous solutionSigma-AldrichS8761
Acid Phosphatase, Lekocyte (TRAP) kitSigma-Aldrich387A
Thiazolyl Blue Tetrazolium Bromide (MTT) powderSigma-AldrichM5655
Dimethyl sulfoxideSigma-AldrichD5879
Alizarin Red S sodium salt, 1% w/v aq. sol.Alfa Aeros42746
Osteoassay bone resorption plates, 24 well platesCorning Life Sciences3987
Multiwell 24 well platesFalcon353504
Flask 75 cm2Falcon353133
Polypropylene Conical Tubes 50 mlFalcon352070
Cell scrapers 30 cmTPP90003

References

  1. Keith, S., Faroon, O., Roney, N., Scinicariello, F., Wilbur, S., Ingerman, L., et al. Toxicological profile for uranium. Agency for Toxic Substances and Disease Registry. , Atlanta, GA. (2013).
  2. Ballou, J. E., Gies, R. A., Case, A. C., Haggard, D. L., Buschbom, R. L., Ryan, J. L. Deposition and early....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

RAW 264 7 CellsUranyl AcetateOsteoclast DifferentiationBone Resorption AssayImageJ AnalysisAlizarin Red StainingTartrate Resistant Acid PhosphataseOsteo Assay Plate